LYEL
#3307
Lyell Immunopharma, Inc. - Common Stock
13.7 7 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.76%
Variación mensual
+3.07%
Variación en los últimos 6 meses
-43.08%
Cambio anual
-43.08%
Cierres anteriores
13.4 0
Open
13.2 6
Mínimo
13.2 6
High
13.8 3
Volumen
8
Financials
- Market Capitalization 321.31 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.47
Relación precio/flujo de caja
11.12 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3232 |  PALI Palisade Bio, Inc. - Common Stock | 1.91 USD | -1.04% | -9.91% | +13.69% | +12.35% | 331.54 M USD | ||
| 3295 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.28 USD | -1.86% | -15.38% | +28.16% | +29.41% | 310.01 M USD | ||
| 3308 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 4.02 USD | -0.74% | +1.26% | +16.18% | +4.15% | 310.30 M USD | ||
| 3314 |  EDIT Editas Medicine, Inc. - Common Stock | 3.13 USD | -0.95% | -17.63% | +28.28% | +12.19% | 306.45 M USD |